UBS O'Connor’s Outlook Therapeutics OTLK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-36,000	Closed	-$266K	–	499
2024 Q2	$266K	Buy	+36,000	New	+$266K	0.01%	385